J07BB01 • pandemic flu vaccine • Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
The pandemic influenza vaccine is used to prevent infections caused by influenza virus strains that have triggered a pandemic. This type of vaccine is rapidly developed during a pandemic based on the responsible virus strain, such as H1N1 (swine flu) in 2009.
The vaccine contains inactivated viral antigens or protein subunits that stimulate the immune system to produce specific antibodies against the pandemic strain. It is administered intramuscularly, usually in one or two doses, depending on public health recommendations.
The vaccine is intended for the general population, with priority given to high-risk groups such as healthcare workers, individuals with chronic illnesses, and the elderly.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. The pandemic influenza vaccine is an essential measure for controlling the spread of the virus during a pandemic and reducing associated mortality and morbidity.
Substance: pandemic flu vaccine
Date of last drug list: 01-07-2013
Commercial code: W54157001
Pharmaceutical form: injection suspension
Quantity: 20
Product type: original
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.